Heffron, ReneeBilek, Kelsey2019-08-142019-08-142019Bilek_washington_0250O_19980.pdfhttp://hdl.handle.net/1773/43905Thesis (Master's)--University of Washington, 2019Background: Long-acting, reversible contraception (LARC) is highly effective; data on LARC use among women in HIV-serodiscordant partnerships are limited. Methods: Prospectively collected longitudinal data from East African women in HIV-serodiscordant partnerships were analyzed using multivariable generalized estimating equations to assess correlates of LARC use. Results: Nine percent (9%) of 679 HIV-positive and 13% of 328 HIV-negative women used LARC at enrollment, and 27% and 20% used LARC at any point, respectively. Correlates of LARC use during follow up included LARC use at baseline, being Kenyan, having condomless sex, and having children already (p<0.05). Conclusion: Women using LARC are most likely to continue LARC use and their experiences are important to share widely as a means of encouraging LARC use among their peers.application/pdfen-USnoneHIV/AIDSImplantsIntrauterine devicesLARCLong-acting reversible contraceptionSerodiscordancyPublic healthGlobal HealthThesis